ArticleCancers2021

Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect.

Tamara Hofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.